Adam M. Burgoyne, MD, PhD, is a distinguished board-certified medical oncologist specializing in the diagnosis and treatment of primary liver cancers and various gastrointestinal malignancies. Dr. Burgoyne utilizes a range of cutting-edge therapies, including personalized medicine approaches, to achieve optimal patient outcomes.
As a physician-scientist, Dr. Burgoyne leads innovative research aimed at enhancing survival rates for individuals with liver cancer and digestive system tumors. His work, published in reputable medical journals, focuses on developing novel drugs and understanding tumor genetics to advance personalized cancer care.
Generated from their website's infomation